ACE inhibitors increase the risk of hypoglycaemia in diabetics;ACE-REMMERS VERGROTEN HET RISICO OP HYPOGLYKEMIE BIJ DIABETICI

Nederlands Tijdschrift voor Geneeskunde

Volumn 140, Issue 8, 1996, Pages 432-436

  Herings, R M C ^a   De Boer, A ^a   Stricker, B H Ch ^b   Leufkens, H G M ^a   Porsius, A J ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CLONIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; INSULIN; LISINOPRIL; ORAL ANTIDIABETIC AGENT; ORAL CONTRACEPTIVE AGENT; PERINDOPRIL; SALICYLIC ACID DERIVATIVE; THYROMIMETIC AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION;

EID: 0030027236     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Arauz-Pacheco C, Ramirez LC, Rios JM, Raskin P. Hypoglycemia induced by angiotensin-converting enzyme inhibitors in patients with non-insulin-dependent diabetes receiving sulfonylurea therapy. Am J Med 1990;89:811-3.
2. Rett K, Wicklmayr M, Dietze GJ. Hypoglycemia in hypertensive diabetic patients treated with sulfonylureas, biguanides, and captopril [letter]. N Engl J Med 1988,319:1609.
3. McMurray J, Fraser DM. Captopril, enalapril, and blood glucose [letter]. Lancet 1986,i:1035.
4. Ferriere M, Lachkar H, Richard JL, Bringer J, Orsetti A, Mirouze J. Captopril and insulin sensitivity. Ann Intern Med 1985;102:134-5.
5. Winocour PH, Waldek S, Anderson DC. Captopril and blood glucose [letter]. Lancet 1986;ii.461.
6. Passa P, LeBlanc H, Marre M. Effects of enalapril in insulin-dependent diabetic subjects with mild to moderate uncomplicated hypertension. Diabetes Care 1987;10:200-4.
7. Seefeldt T, Orskov L, Mengel A, Rasmussen O, Pedersen MM, Moller N, et al. Lack of effects of angiotensin-converting enzyme (ACE)-inhibitors on glucose metabolism in type 1 diabetes. Diabetic Med 1990;7:700-4.
8. Steghieri G, Yin W, Boni C, Sanna G, Anichini R, Bartolomei G, et al. Effect of chronic ACE inhibition on glucose tolerance and insulin sensitivity in hypertensive type 2 diabetic patients. Diabetic Med 1992;9:732-8.
9. Oksa A, Gajdos M, Fedelesova V, Spustova V, Dzurik R. Effects of angiotensin-converting enzyme inhibitors on glucose and lipid metabolism in essential hypertension. J Cardiovasc Pharmacol 1994; 23:79-86.
10. Herings RMC. PHARMO: a record linkage system for postmarketing surveillance of prescription drugs in The Netherlands [proefschrift]. Utrecht: Rijksuniversiteit, 1993.
11. Herings RMC, Bakker A, Stricker BHCh, Nap G. Pharmaco-morbidity linkage: a feasibility study comparing morbidity in two pharmacy based exposure cohorts. J Epidemiol Communnity Health 1992;46:136-40.
12. Herings RMC, Stricker BHCh, Bakker A. Farmacomorbiditeitskoppeling: een orienterende studie naar de technische mogelijkheden in Nederland Ned Tijdschr Geneeskd 1990;134:1903-7.
13. Donnelly R. Angiotensin-converting enzyme inhibitors and insulin sensitivity: metabolic effects in hypertension, diabetes and heart failure. J Cardiovasc Pharmacol 1992;20(Suppl 11):S38-44.
14. Anatomical Therapeutic Chemical Classification (ATC) index: including defined daily doses (DDD) for plain substances. Oslo: World Health Organization, 1992.
15. Gebski V, Leung O, McNeil D, Lunn D, editors. SPIDA user's manual. 6th ed. Eastwood, Australia: Statistical Computing Laboratory, 1992.
16. Uehara M, Kishikawa H, Isami S, Kisanuki K, Ohkub Y, Miyamura N, et al. Effect on insulin sensitivity of angiotensin converting enzyme inhibitors with or without sulphydryl group: bradykinin may improve insulin resistance in dogs and humans. Diabetologia 1994;37:300-7.
17. Berne C. Metabolic effects of ACE inhibitors. J Intern Med Suppl 1991,229:119-25.
18. Everett J, Kerr D Changing from porcine to human insulin. Drugs 1994;47:286-96.
19. Kahn HA, Sempos CT. Statistical methods in epidemiology. New York: Oxford University Press, 1989.
20. Consider insulin resistance when prescribing antihypertensives. Drugs & Therapy Perspectives 1994;4:10-1.